SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics shares surged after topline results from the VK2735 maintenance study showed up to 97% of prior weight loss maintained on every-other-week dosing and roughly 22% placebo-adjusted weight loss over 33 weeks with no plateau, strengthening the drug's obesity-market positioning against Eli Lilly and Novo Nordisk. Traders debated whether the stock was undervalued on the data, with heavy focus on high short interest and potential squeeze dynamics, widespread speculation about buyout or partnership interest from big pharma, and skepticism from some over a muted price reaction, possible dilution via the shelf offering, and the lack of lean-mass data.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry's first Alloy Kore design win  Coretura (founded by Daimler Truck and Volvo Group) selecting the QNX-derived platform in a deal traders cite as adding over $100 million to QNX backlog, pushing it past the $1 billion mark  is driving heavy volume and euphoric bullish sentiment, coming just ahead of Q2 earnings. Reaction is sharply split: longs celebrate the deal and expect more design wins and an earnings beat, while skeptics point to the muted price reaction and warn of 'sell the news' action, shorting pressure, and reliance on strong guidance.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Traders are reacting to heavy selling pressure on The Trade Desk, with the dominant catalyst being its removal from the S&P 500 (moving to the S&P SmallCap 600) and associated index-fund rebalancing. Discussion also centers on anger over a 15% workforce reduction, executive stock grants and option repricing, and persistent underperformance versus adtech peers like Zeta, AppLovin and Magnite, with bulls pointing to heavy short interest and the cash-rich balance sheet while bears cite slowing growth and competitive pressure from Amazon and Google.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending after announcing it became the first U.S. national bank to go live with stablecoin settlement across Mastercard's global payments network, migrating its card program to blockchain-based settlement using SoFiUSD. The community is split between bulls calling it a major catalyst for SoFi's payments ambitions and frustrated traders pointing to a premarket pop that faded, with many alleging market manipulation or criticizing management's silence.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

XNDU is falling sharply as its six-month post-SPAC lockup expires, freeing roughly 200280 million early-investor shares for trading, with traders attributing the sell-off to insider selling pressure on top of dilution concerns from an active ATM program and minimal revenue. The community is split between bulls calling the post-lockup weakness a long-term buying opportunity  citing partnerships with AMD, ASML, and Lockheed Martin plus Canadian government funding  and bears warning the share overhang will keep pressuring the stock for months.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Traders are focused on the U.S.-Denmark-Greenland security agreement, which has put Critical Metals' Tanbreez rare-earth project back in the spotlight after President Trump announced the deal and a planned trilateral signing at the UN. The community is sharply divided: bulls argue the deal de-risks Tanbreez and could lead to U.S. government funding or a stake, fueling short-squeeze hopes given elevated short interest, while skeptics note the agreement covers only military security, not mining rights, and point to the stock's underperformance versus other Greenland-linked names and the company's pre-revenue status.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco shares sold off sharply despite no company-specific announcement, with traders debating whether the drop reflects a Piper Sandler downgrade and price target cut citing peaking growth and lower sector multiples, or broader tech weakness. The community is frustrated by the stock's persistent underperformance after strong earnings, with some calling the price action manipulated while others view it as sector rotation out of the name.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on the Trump administration's ban of major news outlets from the White House press pool and the launch of its own 'Trump TV' state-run media channel, which traders view as directly relevant to Trump Media's platform. The community is sharply divided, with critics calling the moves authoritarian and damaging to the brand, while supporters defend the ban as targeting 'fake news'; related chatter on Iran/Strait of Hormuz tensions and record diesel prices also feeds the political sentiment driving the ticker.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected, and Jefferies cut its price target and free cash flow estimate ahead of the Q3 report. Traders are split between viewing the selloff as an overreactionciting a large backlog, new orders, and BofA's 'overreaction' calland worrying about the looming SPEEA strike vote and China order uncertainty.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Federal Reserve's first rate hike in three years and hawkish guidance from Chair Warsh dominate the conversation, with traders debating how higher-for-longer rates and elevated Treasury yields will pressure small caps, which have lagged large-cap tech and hit multi-month lows. The community is split between bears expecting the Russell 2000 to test the 200-day area and dip-buyers anticipating a rotation into small caps once mega-cap leadership fades, alongside heavy put activity and 0DTE options speculation around the move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ABCL  👀🚨 $15.29-$16.89 this week‼️ 

GET in NOW here @ $12.67’sss going to $14’sss today!! DON’T MISS OUT!! 

LARGEST IMS 2026 MENOPAUSE THERAPEUTIC CONVENTION CONFERENCE in a few days!! 🤯 

$ABCL 🚨👀 PART 1/2

🧬 ABCL635 — Next Data Disclosure Date Has Been Set

📢 AbCellera has officially announced that it will present Phase 2 efficacy and safety data 

(Phase 2 Results 12 WEEK DATA 📊 (the 90 DAY’s) for ABCL635 orally at the IMS World Menopause Society meeting on October 1.

The key takeaway from this announcement isn’t just;participating in the conference;

🔹 August disclosure → Primarily 4-week topline data
🔹 October 1 → Formal presentation of Phase 2 data on the academic stage

In other words, the date for the next data readout on 635 has been clarified. 🎯

Click on this message to see PART 2/2!!

Stonk Trades

$ABCL 👀🚨Can’t imagine you plan a Menopause Therapeutic Data Release at the Largest 2026 IMS World Menopause Conference to Share bad results?! ABSOLUTELY 💯 NOT!

LAST CHANCE!! This is the time to LOAD UP!!! Buy all you can here at $12.67’s. We about to Squeeze to Mid-13’sss. It’s going to HAPPEN so FAST!!! 

MM’s and Shorts can NO LONGER keep $ABCL back at Lower Prices!! The Chart 📈 is PRIMED to SQUEEZE‼️

🚨IMS LARGEST MENOPAUSE Convention Conference in a few days!!! 😮 🤯 

🚨AT the Conference they are going to be Releasing the PHASE II RESULTS 12 WEEK DATA 📊 ( the 90 Days) yea we going to the $20’sss! 

Good luck keeping this down!! We are in a BREAK-OUT $17-$23’ss by next WEEK!

SMART Money Positioning ahead of the Pipeline.

Best 30 minute Conference Call I HAVE EVER LISTENED TOO!!!

🚨 🚨🚨CEO CARL Quoted Phase II RESULTS were so IMPRESSIVE that “Patients were “CURED” after 4 weeks. From 10events a day to “ZERO” 🤯 

BLACKROCK INC. THE #1 Financial Institution went 15M to 45M $ABCL Shares‼️

StockTwits for iOS

AbCellera Biologics Inc

  👀🚨 $15.29-$16.89 this week‼️ 

GET in NOW here @ $12.67’sss going to $14’sss today!! DON’T MISS OUT!! 

LARGEST IMS 2026 MENOPAUSE THERAPEUTIC CONVENTION CONFERENCE in a few days!! 🤯 



 🚨👀 PART 1/2

🧬 ABCL635 — Next Data Disclosure Date Has Been Set

📢 AbCellera has officially announced that it will present Phase 2 efficacy and safety data 

(Phase 2 Results 12 WEEK DATA 📊 (the 90 DAY’s) for ABCL635 orally at the IMS World Menopause Society meeting on October 1.

The key takeaway from this announcement isn’t just;participating in the conference;

🔹 August disclosure → Primarily 4-week topline data
🔹 October 1 → Formal presentation of Phase 2 data on the academic stage

In other words, the date for the next data readout on 635 has been clarified. 🎯

Click on this message to see PART 2/2!!

$ABCL 🚨👀 PART 2/2

Key points to watch for in particular 👇

⏳ Durability of efficacy after 4 weeks
📊 Patient-specific responses and detailed data on complete resolution (complete symptom resolution)
🛡️ More detailed safety data
💉 Additional information supporting dosing and administration intervals for Phase 3

That said, the significance is clear.

🧬 AbCellera is still officially describing 635 as;potential best-in-class; and
is now taking its first GPCR clinical asset to the stage of full validation on the academic platform.

🚀 This isn’t an announcement of a new clinical success.

But October 1 marks the next checkpoint to see how much deeper data will back up the Phase 2 success of 635.

 🚨👀 PART 2/2

Key points to watch for in particular 👇

⏳ Durability of efficacy after 4 weeks
📊 Patient-specific responses and detailed data on complete resolution (complete symptom resolution)
🛡️ More detailed safety data
💉 Additional information supporting dosing and administration intervals for Phase 3

That said, the significance is clear.

🧬 AbCellera is still officially describing 635 as;potential best-in-class; and
is now taking its first GPCR clinical asset to the stage of full validation on the academic platform.

🚀 This isn’t an announcement of a new clinical success.

But October 1 marks the next checkpoint to see how much deeper data will back up the Phase 2 success of 635.